US2011054153A1PendingUtilityA1
Method of purifying apo-2 ligand/trail usin crystallisation the cold
Est. expiryNov 13, 2021(expired)· nominal 20-yr term from priority
C07K 14/435A61K 9/0019A61K 47/02A61K 33/30A61K 38/16A61K 45/06A61K 9/19C07K 14/70575A61K 33/00A61K 47/183A61K 47/26A61K 31/198
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates generally to Apo2L/TRAIL purification involving crystallization.
Claims
exact text as granted — not AI-modified1 . A method of recovering Apo2L/TRAIL from a mixture comprising
(a) loading the mixture on a cation exchange column; (b) washing the cation exchange column with an equilibration buffer whereby non-binding components present in the mixture are removed; (c) eluting Apo2L/TRAIL bound to the cation exchange column with an elution buffer; (d) gradually cooling the eluate to a temperature of about 2 to 4° C., whereby Apo2L/TRAIL is spontaneously precipitated in a crystalline form to yield a mixture of mother liquor and Apo2L/TRAIL crystals, and (e) recovering Apo2L/TRAIL from the mixture obtained in step (d) in a purity of at least about 99%.
2 . The method of claim 1 wherein the mixture loaded on the cation exchange column is a culture medium or cell lysate of Apo2L/TRAIL producing cells.
3 . The method of claim 2 wherein said mixture is the cell lysate of Apo2L/TRAIL producing E. coli host cells.
4 . The method of claim 3 wherein said lysate is clarified prior to loading on the cation exchange column.
5 . The method of claim 1 wherein the eluate obtained in step (c) is subjected to the crystallization step of (d) without additional purification.
6 . The method of claim 1 wherein the cation exchange column is an SP-Sepharose column.
7 . The method of claim 6 wherein the pH of the mixture loaded on said column is or is adjusted to about 7.5.
8 . The method of claim 6 wherein elution of Apo2L/TRAIL is performed in an elution buffer comprising 100-200 mM NaCl or 100-150 mM Na 2 SO 4 in a buffer adjusting the pH to 7.5-7.8.
9 . The method of claim 1 wherein in step (d) the eluate is cooled from a temperature of about 15 to 30° C. to a temperature of about 2 to 8° C. in about 1 to 60 hours.
10 . The method of claim 9 wherein in step (d) the eluate is cooled to a temperature of about 2 to 8° C. in about 1 to 8 hours.
11 . The method of claim 9 wherein in step (d) the eluate is cooled to a temperature of about 2 to 8° C. in about 1 hour.
12 . The method of claim 11 wherein in step (d) the eluate is cooled to a temperature of about 4° C. in about 1 hour.
13 . The method of claim 1 wherein the pH of the eluate is or is adjusted to pH 7.0-8.0 prior to crystallization.
14 . The method of claim 13 wherein the pH of the eluate is or is adjusted to about 7.3 prior to crystallization.
15 . The method of claim 13 wherein the pH of the eluate is or is adjusted to about 7.5-8.0 after crystallization.
16 . The method of claim 1 wherein in step (d) the temperature of about 2 to 4° C. is maintained until equilibrium solubility of Apo2L/TRAIL is achieved or nearly achieved.
17 . The method of claim 16 wherein in step (d) solubility of Apo2L/TRAII is decreased by the addition of an anti-solvent.
18 . The method of claim 17 wherein said anti-solvent is selected from the group consisting of a polyethylene glycol (PEG), MPD, ethanol, isopropanol, and dioxane.
19 . The method of claim 18 wherein the molecular weight of the PEG is between about 400 and about 10,000 daltons.
20 . The method of claim 19 wherein the molecular weight of the PEG is 400, 3,350 or 10,000 daltons.
21 . The method of claim 1 wherein in step (e) Apo2L/TRAIL is recovered in the form of crystals separated from the mother liquor by filtration or centrifugation or a combination thereof.
22 . The method of claim 21 wherein pH of the mother liquor is adjusted to about 8.0 prior to filtration to decrease solubility.
23 . The method of claim 1 further comprising the steps of dissolving the Apo2L/TRAIL crystals obtained in step (d) and subjecting the solution obtained to a second chromatographic purification step.
24 . The method of claim 23 wherein said second chromatographic purification step is hydrophobic interaction chromatography.
25 . The method of claim 24 wherein hydrophobic interaction chromatography is performed on a Phenyl-Sepharose column.
26 . The method of claim 23 wherein said second chromatographic purification step is cation exchange chromatography.
27 . The method of claim 26 wherein said cation exchange chromatography is performed on an CM-Sepharose or SP-Sepharose column.
28 . The method of claim 23 wherein Apo2L/TRAIL is recovered and formulated following said second chromatographic purification step by ultrafiltration-diafiltration.
29 . The method of claim 1 wherein said purity is at least about 99.5%.
30 . The method of claim 1 wherein said purity is at least about 99.9%.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.